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Abstract
Background
Illnesses and interventions can affect the health status of family carers in addition to
patients. However economic evaluation studies rarely incorporate data on health status of
carers.
Objectives
We investigated whether changes in carer health status could be ‘predicted’ from the health
data of those they provide care to (patients), as a means of incorporating carer outcomes in
economic evaluation.
Methods
We used a case study of the family impact of meningitis, with 497 carer-patient dyads sur-
veyed at two points. We used regression models to analyse changes in carers’ health sta-
tus, to derive predictive algorithms based on variables relating to the patient. We evaluated
the predictive accuracy of different models using standard model fit criteria.
Results
It was feasible to estimate models to predict changes in carers’ health status. However,
the predictions generated in an external testing sample were poorly correlated with the
observed changes in individual carers’ health status. When aggregated, predictions pro-
vided some indication of the observed health changes for groups of carers.
Conclusions
At present, a ‘one-size-fits-all’ predictive model of carer outcomes does not appear possible
and further research aimed to identify predictors of carer’s health status from (readily avail-
able) patient data is recommended. In the meanwhile, it may be better to encourage the
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targeted collection of carer data in primary research to enable carer outcomes to be better
reflected in economic evaluation.
Introduction
It is increasingly recognised that the health benefit that family carers may derive from health-
care interventions is a relevant consideration in economic evaluation, whether one takes a
societal or healthcare perspective [1,2]. This is underscored by recent guidance from the 2nd
US Panel on cost-effectiveness which advocates “the reference case cost-effectiveness analysis
[should include] QALYs accruing to patients and to any other affected parties such as caregivers”
([3], p.1097). There is also a policy imperative to this, given the increasing reliance European
health systems have on family care. One way in which carers’ health and wellbeing can ulti-
mately be maintained is by considering these outcomes at the outset when evaluating health
and social care interventions [4].
Obtaining data on carers’ outcomes in addition to patients’ outcomes as part of a clinical
trial, or an observational study, is an obvious way of building carer outcomes into economic
evaluation. In practice, though, this may not always be feasible. One option might be to ‘pre-
dict’ carer outcomes based on other data collected in a primary research study, for example
patient outcomes. In this study, we set out to assess whether changes in carers’ health status
could be predicted from data relating to the patient’s health. The study was conducted in the
UK, using the chronic after-effects of meningitis, as the clinical case study. Vaccinating against
meningitis may yield health benefit, not just for patients, but also for the wider family network,
if vaccination reduces long-term morbidity from meningitis and the associated caring respon-
sibilities of family members [5]. Our specific objectives were:
1. To examine whether it was feasible to predict changes in health status for carers at the indi-
vidual level using patient health and demographic data; and
2. To examine predictions for subgroups of carers, given that economic evaluation is based on
the mean health effects falling on a group of the population
In the following section we review the relevance of carer outcomes in economic evaluation,
the potential for predicting carer health status from patient health data, and outline a concep-
tual framework for study. We then describe our methods to collect data, estimate predictive
models, and test their predictive accuracy. The results and implications are discussed in the
final two sections.
Background
Informal care in economic evaluation
In an economic evaluation, informal care can be considered on both the input and outcome
side [6–8]. On the input side, the time devoted to caregiving represents a ‘resource’ that can be
used up [9,10]. On the outcomes side, a carer’s wellbeing can be affected by both the process of
informal care and the distress of seeing a loved one in poor health [7,11,12]. Economic evalua-
tions that take a wide societal perspective ought to consider both the costs and outcomes asso-
ciated with informal care [1], whilst paying attention to the potential for double counting
[7,13,14]. If a healthcare perspective is taken in the economic evaluation of health technologies,
then carers’ time cannot be considered in the analysis as the costs are borne by agents outside
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the healthcare system; however, under the healthcare perspective carers’ health outcomes
remain relevant [1,15–17].
One approach to valuing carers’ quality of life outcomes is to use quality of life tools to mea-
sure the carers’ quality of life and ‘off-the-shelf’ social tariffs to value changes in quality of life
[18]. Quality of life tools include those capturing health-related quality of life [15,19], care-
related quality of life [20,21] and capabilities [22–24]. An advantage of using health-related
quality of life measures is that carer and patient outcomes are measured using the same
numeraire and estimation of the total health impact of the disease/technology can be more eas-
ily derived. Additionally clinical studies may measure carer burden or quality of life using a
non-preference-based measure [25]. These outcomes may potentially still be considered in an
economic evaluation as part of a cost-consequence analysis [26,27].
A second approach is to value carers’ outcomes directly. This can be done using time trade-
off or standard gamble techniques to estimate how much of their own life a carer would be
willing to sacrifice to improve a patient’s health state [28,29]. Alternatively, carers can be asked
to express how much they would be willing to accept to undertake more caring tasks [30]. This
provides a monetary valuation of the impact of caring that (in theory) incorporates the health
effects of caring.
In this study, we focus on the health-related quality of life approach to valuing carer out-
comes, as this is consistent with most guidance for applied economic evaluation [16]. For
example, recent NICE guidance, which takes a healthcare perspective, suggests that analysts
ought to comprise all direct health effects, including those falling on carers [31]. Similarly,
where a societal perspective for economic evaluation has been advocated, for example in the
Netherlands or the United States, the inclusion of carer health has also been recommended
[1,3].
Reviews of applied economic evaluations show that carer outcomes are rarely considered in
applied economic evaluations [32], even for conditions associated with substantial informal
care burden [2]. This is of concern for two reasons; first if included, carer outcomes would be
expected to alter the incremental cost-effectiveness ratio and in some cases this may affect
technology adoption recommendations [2,15,33]; second, neglecting carer outcomes overlooks
important equity implications of funding decisions. As data on patient outcomes will invari-
ably be available when evaluating the cost-effectiveness of an intervention, it seems pertinent
to explore whether this can be used to predict outcomes for carers, to enable the consideration
of both outcomes within an economic evaluation.
The relationship between carer and patient outcomes
Any predictive modelling of carer health from patient data assumes an underlying association
between the outcomes of carers and patients. A theoretical basis for anticipating that patient
and carer outcomes are likely to be intertwined comes from psychological models of stress
adapted to the caregiving context [34]. Caring for someone in poor health is a potentially
stressful experience that may result in a range of adverse outcomes, including adverse health
outcomes, for the carer. Stress is likely to arise from ‘primary’ factors such as the patient’s
dependency and ‘secondary’ factors resulting from that dependency, such as family conflicts
[34].
It has also been noted that the combined effects of prolonged distress, the physical demands
of caregiving, and the biological vulnerability of some carers may affect carers’ physical health
[35]. Carers’ health may also suffer if they can no longer undertake joint physical activities
together with the patient, such as exercise or leisure. The psycho-social nature of caring means
that the most significant effects of caring will often be in terms of the carers’ mental health
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[36–39]. However, the psychological impact of caring will vary from carer to carer and there is
evidence of positive aspects of caring, such as fulfilment and relationship benefits for many
carers [40–42].
A number of studies reveal that patient disability adversely affects carer health across a wide
range of clinical conditions, including childhood illness [43] and neurological conditions [44].
Econometric modelling of carer wellbeing suggests carers suffer from worse wellbeing than
non-carers, and that carer wellbeing is progressively lower as the recipient’s care needs in-
crease [45]. However, the relationship between carer health and patient outcomes is not a sim-
ple one and is unlikely to be consistent across conditions. [18] p.496 suggest: “. . .most of the
literature reported small negative effects [of patient illness on the carer]. . . likely correlated with
the condition, population affected, as well as measurement technique. . .”.
A conceptual framework for predicting changes in carers’ health status (ΔHC) is laid out in
Fig 1. This postulates that ΔHC could be associated with a new patient treatment if there is an
underlying relationship between the change in carer health status and patient health status
(ΔHP). In estimating the total effects of the intervention one should in theory consider ΔHP
and ΔHC. The latter could be directly calculated by measuring a carer’s health status before
and after an intervention. Alternatively ΔHC could be directly predicted from ΔHP and other
variables that are likely to be related to ΔHC such as those listed on the right-hand side of the
figure. Table 1 summarises some of the likely determinants of ΔHC. Of course there are multi-
ple determinants of ΔHC and only some of these, such as patient health and certain demo-
graphic characteristics, may be easily obtained from a particular study.
Fig 1. Conceptual framework for predicting health effects of treatments on carers. A causal relationship between patient and carer outcomes is
hypothesised, based on what we know about the experience of informal care. However, for the purposes of the modelling, we assume only that there is
an association between the two outcomes. Where we anticipate an association (for example between the treatment and ΔHP, or between the caring
situation and ΔHC) we have used dashed lines.
https://doi.org/10.1371/journal.pone.0184886.g001
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Methods
This research is based partly on data collected for an earlier study of the family impact of men-
ingitis [5]. For the purpose of the present study we followed-up participants to the survey,
measuring their health status and the health status of patients (i.e. survivors of meningitis) at
baseline and after 12 months. We used these data to examine whether changes in carers’ health
status could be predicted using changes in patients’ health status. Details of the earlier study,
further data collection, and estimation and testing of predictive models are reported below.
The study protocol was approved by the University of Birmingham’s Life and Health Sciences
Ethical Review Committee (ERN_11–0191).
Family impact of meningitis case study
Meningitis is a potentially deadly condition, but most patients survive the disease. Of those
who do survive, a sizeable minority (around 20–30%) will develop long-term physical or men-
tal health problems, such as learning difficulties, hearing and sight loss, and balance problems
[47,48]. Meningitis is most prevalent amongst the very young, so any after-effects are likely to
affect family carers of the survivors of meningitis. Because meningitis is associated with a
range of long-term health problems, but is potentially preventable, it provides an important
case study in understanding the nature of spillover impacts on carers.
The baseline data for this study come from a UK-wide survey of families affected by menin-
gitis. The study was conducted in May 2012, and data were gathered on the health status (and
many other outcomes) of 1,218 survivors of meningitis (‘patients’) and 1,587 family members.
Most family members were parents of the patients. Given the young age and high level of dis-
ability of many patients, data about the patient was proxy-reported by the family members.
Recent analysis of these data suggested proxy-reporting did not introduce any systematic bias
to the association between family member and patient health status [5]. The earlier study
focused on measuring the impact of meningitis on the health status of family members. The
findings of this previous study have been used in decision-modelling that showed that the
cost-effectiveness of MenB vaccination was sensitive to a number of factors, including the
assumption made about the scale of family impact [49]. This re-evaluation of cost-effectiveness
Table 1. Potential determinants of carer health status.
Nature of relationship
Patient health status Greater patient impairment is associated with poorer carer health status [12,18].
Improvements in any aspect of the patient’s health status would be anticipated to
have a positive impact on carer health status, given the potential for reduced
informal care needs and anxiety over the patient’s condition.
Patient
characteristics
There is some evidence that suggests caring for older patients and/or male
patients is associated with higher carer burden [25]. Thus changes in carer health
status may be related to the patient’s age and sex.
Patient healthcare
use
If the patient receives formal healthcare this may relieve some of the burden on
the carer, benefitting the carer’s health status. However, the receipt of formal
healthcare may signify a serious and stressful episode for the patient and
therefore be associated with negative impacts on the carer’s life.
Caring situation Specific features of the caring situation such as the nature of the caring
relationship, the amount of care provided, and the type of tasks undertaken may
impact on the carer’s health status [35,39]. In general increases in caring
responsibilities and co-residential care to a close relation would be expected to
adversely affect carer health status.
Non-care-related
factors
The health status of carers, as with other member of the population, will also be
affected by their own age, sex, genes and environment [36,46].
https://doi.org/10.1371/journal.pone.0184886.t001
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also influenced the UK advisory body on vaccination who subsequently recommended vacci-
nation [49,50]. In the present study we are interested in the methodological question of
whether carer health effects (ΔHC) could be ‘predicted’ from data relating to the patient.
Further data collection for predictive modelling
We collected data at two time points which enabled us to observe and predict changes in health
status for individual carers. Previous studies have adopted cross sectional designs focused on
predicting outcomes at a single point in time [51,52]. Collecting data at two time points how-
ever provides a more direct, and potentially valuable, test of predictive ability of models as it is
ultimately changes in health status (rather than the health status per se) that are used to esti-
mate benefits within economic evaluation.
In May 2013, we sent a 14-page follow-up questionnaire to all family members who
returned a questionnaire in 2012 or were involved in the pilot study (n = 1,627). The format
for the follow-up questionnaire was very similar to the baseline questionnaire, which had been
piloted with a focus group (n = 6) and a sample of family members (n = 30). The follow-up
questionnaire was completed by family members and included sections on:
• The health status of the patient
• The after-effects of meningitis
• The social network of the patient
• Informal care provided by the family member
• The health status and wellbeing of family member
• Perceptions of how meningitis had affected the family over the last year.
Our particular focus in this study is on the health status data. For both family members and
patients, health status was measured using the EQ-5D-5L [53]. This is a preference-based
generic measure of health related quality of life, widely used to measure population health [54]
and to inform value for money assessments carried out for a number of funding bodies, e.g.
NICE, SMC, CADTH, PBAC, CVZ [55] The EQ-5D-5L is built around 5 dimensions of health
(mobility, self-care, usual activities, pain and discomfort, and anxiety and depression), each
with 5 possible levels of severity (no problems, mild problems, moderate problems, severe
problems, and extreme problems). To estimate health status on a 0 (death) to 1 (full health)
scale, we scored responses to the EQ-5D-5L questionnaire using interim value sets for the UK
[56].
We included questionnaires in a survey pack with information about the study and a pre-
paid reply envelope and posted these to 1,627 family members in the sample frame. Reminder
postcards were sent to all members after one week and reminder letters to all non-responders
after four weeks. We excluded respondents if the patient had died, the family member had
become estranged from the patient, a different family member responded to the follow-up
questionnaire, the family member switched focus to a different patient at follow-up, or the
patients themselves completed the survey questionnaire. We entered data into a secure data-
base, with 5% of questionnaires being double entered to verify the accuracy of data entry.
Estimating predictive models of changes in carers’ health status
In order to predict ΔHC for ‘carers’ (as opposed to family members more broadly) we
restricted the sample in two ways. First, we excluded family networks where the patient did
not develop after-effects from meningitis. Second, we included only one respondent from each
Carer effects in economic evaluation
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of the family networks. In cases where family networks contained two respondents, data on
co-residence, social contact, relationship, employment status and gender were used to deter-
mine which family member was likely to be closest to the respondent [5]. This process gener-
ated a sample of unique carer-patient dyads, where all patients had some degree of health
problem.
We then split carer-patient dyads into two equal-sized random samples–a training sample
and a testing sample. Other methods exist for checking predictive accuracy of models; these
would have allowed us to retain the full sample for estimating the model. Methods include (i)
external validation with a different dataset; and (ii) internal validation. Because no external
dataset was present, splitting the sample provides a way of conducting internal validation and
checking whether the model predictions are generalisable beyond the dataset used to develop
them. We used the training sample to estimate the predictive models. The testing sample pro-
vided an external sample for testing the predictive accuracy of the models. We used the train-
ing sample to predict ΔHC, assessed using the EQ-5D-5L, between baseline and follow-up (i.e.
over 12 months). The ΔHC variable provides a summary measure of carer health, which could
be utilised within an economic evaluation.
We estimated four predictive models of ΔHC:
• Model 1: This model predicted ΔHC as function of change in each of the five individual items
of the patient health status (described using the EQ-5D-5L). The intuition for this model is
based on cross-sectional data analyses indicating an association between the health status
scores of carers and patients [12,43,57]. This model is based on evidence suggesting that some
aspects of patient health may affect carer health status more than others [57,58]. To assess the
change in each item of the patient’s EQ-5D-5L, we generated five categorical variables to indi-
cate whether there had been an improvement, a decline, or no change in each item.
• Model 2: This model predicted ΔHC as a function of any changes in the disabling after-
effects of meningitis for the patient (in addition to the variables included in model 1). The
purpose of this model was to examine whether ‘clinical’ data on the patient in addition to
their health status might better predict ΔHC. Information was collected in the survey (at
baseline) about the presence or absence of specified after-effects of meningitis [5]. Informa-
tion was then collected in the follow-up survey on whether any of the specified after-effects
had improved or worsened. We used dummy variables to represent the presence or absence
of any of the five most commonly reported after-effects of meningitis. There were beha-
vioural/emotional problems, mild learning disabilities, scarring, balance problems, and
speech and language problems. We also explored the use of categorical variables representing
(carer-perceived) improvements or worsening in each of the five most commonly reported
after-effects.
• Model 3: This model predicted ΔHC as a function of patient healthcare use (in addition to
the variables included in model 2). We used this model to examine whether patient health-
care use–which may provide additional information on patients care needs–aided the pre-
diction of ΔHC. We used three categorical variables to indicate whether, over the last 12
months, the patient used GP services, hospital services as an outpatient, and hospital services
as an inpatient.
• Model 4: This model predicted ΔHC as a function of characteristics of the informal carer (in
addition to the variables included in model 3). We included variables relating to the carers’ age,
sex, relation to the patient, co-residence, and provision of daily care. Whilst the purpose of this
study is to determine whether patient data can be used to predict ΔHC, we used this model to
verify whether carer-specific information is needed to accurately predict carer outcomes.
Carer effects in economic evaluation
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In all models we additionally controlled for the patient’s age and sex, as these data are likely
to be collected routinely in clinical studies. We estimated all models using OLS regression, as
ΔHC was approximately normally distributed in this sample. We also investigated two alterna-
tive modelling strategies. We first used an adjusted limited dependent variable mixture model.
This is recommended as a method for dealing with non-unimodal distributions and gaps in
values [59]. We also used a Beta regression model. This is recommended as a method for deal-
ing with the truncated range of values of health-related quality of life data [60]. Comparisons
between the estimation strategies revealed very little difference in terms of the p-values pro-
duced for individual variables, with OLS performing slightly better across all models on the
basis of AIC ad BIC statistics. The comparisons between estimation techniques are shown in
the supporting information (S1 File).
Following OLS estimation of the four models, we used each model to predict changes in
carers’ EQ-5D-5L scores, within the training sample and within the external testing sample.
Analysis was conducted on carer-patient dyads where there were complete data across all rele-
vant covariates.
Testing predictive models
We first assessed the accuracy of the four predictive models in terms of how well the models
predicted the observed ΔHC at the individual level. For each of the four models, we generated
two sets of predictions, one for the training sample and one for the testing sample. We com-
pared each pair of predictions against the observed ΔHC in the training and testing sample.
For each comparison, we calculated the correlation between the observed and predicted values,
the range of prediction errors, the mean absolute prediction error, and the root mean squared
prediction error.
The second investigation focused on whether the models accurately predicted the mean
ΔHC over 12 months for groups of carers. This investigation was conducted because ΔHC
would be aggregated in trials and economic evaluations of healthcare interventions, rather
than used to make judgements about the likely health outcomes of specific carers. The mean
health effect for a group of carers (or family members) can be estimated and summed with the
mean health effect for patients to calculate an incremental cost-effectiveness ratio [61]. A
framework for including the family spillovers within economic evaluation is presented else-
where [17]. We assigned carers to sub-groups based on whether the patient’s condition
improved or worsened over the 12 months. This was a pragmatic way of trying to generate
sub-groups of carers that might be experiencing different positive or negative spillovers from
changes in the underlying clinical condition of the patient. We assigned carers to one of three
groups based on whether: (i) one or more patient after-effects had improved over the last 12
months; (ii) there was no change in patient after-effects over the last 12 months; (iii) one or
more patient after-effects had worsened over the last 12 months. We classified cases where one
(or more) after effect improved and one (or more) after effect worsened as ‘mixed change’ and
excluded these from this analysis as a non-‘Pareto’ change [54]. To predict the mean ΔHC, we
averaged the individual predictions of ΔHC within each of the subgroups of carers. We assessed
the accuracy of predictions at the group level by comparing the mean of the observations of
ΔHC, with the mean of the predictions of ΔHC.
Results
Data
The response to the baseline survey on the family impact of meningitis is reported elsewhere [5].
When we followed up respondents 12 months later, we received 1038 responses. A total of 14
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(1%) individuals declined to participate and 3 individuals were identified as ineligible prior to
questionnaires being returned. During the process of data entry and cleaning, an additional 16
individuals were deemed ineligible, resulting in 1022 useable responses (net response rate 64%).
The final sample included 497 carer-patient dyads (Table 1) after exclusion of respondents
not relevant to the predictive modelling. At baseline, the mean age of patients was 25 years old
(SD 17). Around half of patients had some problems with anxiety or depression and over one-
third had some limitations in usual activities and pain/discomfort. Carers also frequently reported
limitations in their own health status, with over one-third reporting some anxiety or depression
and over one-third reporting some pain or discomfort. Just over three-quarters of carers were
parents of the patient. Only a minority of carers provided daily informal care for the patient.
The mean health status of both carers and patients deteriorated over the 12 months
(Table 2). This deterioration on average in the health status of these two groups masks a wide
range of improvements and deteriorations at the individual level. Specifically, 23% of carers
and 24% of patients experienced an improvement in health status over the 12 months, and
36% of carers and 38% of patients experienced deterioration.
Figs 2 and 3 show the distribution of changes in carers’ and patients’ EQ-5D-5L scores.
While a majority of carers and patients experienced some change in health status over the 12
months, large numbers had no reported change (hence the peaks at 0). Improvements in carer
health status were more likely to occur when patient health status also improved (p< 0.01)
suggesting some underlying basis for predicting ΔHC using patient health status.
Models to predict changes in carers’ EQ-5D-5L scores
Of the 497 carer-patient dyads, 249 were randomised to the training sample, and 248 were ran-
domised to the testing sample. There were no significant differences (p<0.05) between carers
and patients in the two samples, in terms of their health status, age or sex.
Table 3 shows the estimation of the four models to predict changes in carers’ EQ-5D-5L
scores over 12 months. In model 1, the signs on the coefficients for improvements and deteri-
orations in aspects of the patient’s health status are mostly in the expected direction. For ex-
ample a decline in patient mobility is associated with negative ΔHC and an improvement in
patient mobility with positive ΔHC. However there were anomalies, albeit statistically non-sig-
nificant ones, such as the association between improvements in patient anxiety and depression
and negative ΔHC. In model 2, only one of the additional five variables representing patient
after-effects was significant at p<0.05. This was the presence of balance problems at baseline
which was associated with a greater decline in carer health status. In model 3, the patient’s GP
and inpatient care use over the last 12 months was associated with increased carer health status
and the patient’s outpatient care use being associated with decreased carer health status. In
model 4, the transitions into daily care and living with the care recipient were associated with
positive ΔHC as a biological relationship between patient and carer, although the latter was the
only association significant at p<0.05.
Predictive accuracy of models–individual level
The predictive accuracy of the four models is summarised in Table 4. Plots of the observed and
predicted values indicated a tendency for improvements in carer health status to be under-pre-
dicted by the models and deteriorations to be over-predicted. Table 4 shows medium to strong
correlations [62] between predicted and observed values in the training sample. However, the
table also shows, for all models, the correlations between predicted and actual ΔHC in the test-
ing sample were negligible and non-significant. In the testing sample, the MAE and RMSE
also increased with the addition of extra variables (i.e. from model 1 through to 4).
Carer effects in economic evaluation
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Predictive accuracy of models–group level
As noted in 3.4, we generated three groups of carer-patient dyads to examine predictive accu-
racy at the aggregate level. Eighty (19%) carer-patient dyads experienced one or more after-
Table 2. Characteristics of patients and carers in the predictive modelling sample.
Baseline Follow-up
(n = 497) (n = 497)
Patient
Health status†
EQ-5D-5L (mean, SD) 0.79 (0.28) 0.77 (0.28)
Mobility problems (%) 23% 26%
Self-care problems (%) 19% 20%
Usual activities problems (%) 38% 40%
Pain problems (%) 35% 40%
Anxiety/depression problems (%) 45% 53%
Meningitis-related after-effects‡
Behavioural/emotional problems 41% 28% improved and 37% worse
Mild-moderate learning disability 23% 16% improved and 25% worse
Scarring 20% 23% improved and 13% worse
Balance problems 18% 13% improved and 19% worse
Speech or language impairment 17% 25% improved and 16% worse
Healthcare use in last 12 months
GP 68%
Hospital (outpatient) 50%
Hospital (inpatient) 15%
Age (mean, SD) 24.9 (17.3) 25.9 (17.3)
Sex (% female) 46% 46%
Carer
Health status
EQ-5D-5L (mean, SD) 0.86 (0.18) 0.84 (0.20)
Mobility problems (%) 16% 17%
Self-care problems (%) 4% 4%
Usual activities problems (%) 17% 18%
Pain problems (%) 36% 41%
Anxiety/depression problems (%) 42% 48%
Age (mean, SD) 51.9 (11.7) 52.9 (11.7)
Sex (% female) 88% 88%
Relation to survivor
Parent (%) 78% 78%
Partner (%) 10% 10%
Grandparent (%) 7% 7%
Other (%) 5% 5%
Co-resident (yes) 64% 60%
Provide daily informal care (yes) 20% 25%
†‘Problems’ in each EQ-5D-5L item refer to a response of level 2 or lower.
‡The follow-up questionnaire included questions about whether the severity of after-effects had changed,
rather than whether or not they were present. The second column reports the proportion of those with after-
effect who experienced an improvement/no change/worsening over the 12 months.
https://doi.org/10.1371/journal.pone.0184886.t002
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effects improving and were allocated to the first sub-group. Two-hundred and eight (50%)
carer-patient dyads experienced no change in after-effects and were allocated to the second
sub-group. Ninety-two (22%) carer-patient dyads experienced one or more after-effects wors-
ening and were allocated to the third sub-group. Finally 35 (8%) carer–patient dyads experi-
enced mixed change in after-effects and were excluded from this element of the analysis.
Table 5 summarises the mean observed and predicted ΔHC for the three sub-groups. In this
analysis, the predictions came from model 3; this was the model that used patient data that per-
formed best in terms of explanatory power and predictions within the training sample. Table 5
indicates that the difference between the mean predicted changes and mean observed changes
ranges from 0.002 to 0.020 across the six sub-groups.
Discussion
The aim of this study was to investigate whether it was possible to use patient data to predict
changes in the health status of family carers. We found that it was feasible to estimate models
to predict changes in carers’ health status. However the predictions generated were poorly cor-
related with the observed changes in carers’ health status in an external testing sample.
Fig 2. Distribution of change in patient’s EQ-5D-5L scores (n = 454).
https://doi.org/10.1371/journal.pone.0184886.g002
Fig 3. Distribution of change in carer’s EQ-5D-5L score (n = 474).
https://doi.org/10.1371/journal.pone.0184886.g003
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The predictor variables were included on theoretical grounds, to cover the factors that affect
the carer’s health status that might be collected routinely in clinical studies. In our regression
models most of the predictor variables were found to be non-significant and these variables
sometimes had counterintuitive signs. In terms of the patient’s health status, changes in mobil-
ity appeared to be the most important predictor of ΔHC. The positive impact of improved
patient mobility on carer health status is consistent with the broader literature showing a posi-
tive association between carer and patient health status [12,63]. However the apparent promi-
nence of patient mobility seems to conflict with other studies that have suggested that the
Table 3. Models to predict carer EQ-5D-5L changes (ΔHC) from patient data.
Variables MODEL 1 MODEL 2 MODEL 3 MODEL 4
Constant -0.019 (0.31) -0.026 (0.22) -0.024 (0.34) 0.036 (0.48)
PATIENT DEMOGRAPHICS
Age (years) 0.000 (0.72) 0.000 (0.33) -0.000 (0.55) -0.001 (0.26)
Sex (male) -0.021 (0.22) -0.021 (0.21) -0.014 (0.43) -0.013 (0.45)
PATIENT HEALTH STATUS CHANGE
Mobility worsening -0.091 (0.01) -0.087 (0.02) -0.084 (0.02) -0.070 (0.06)
Mobility improvement 0.105 (0.01) 0.117 (0.01) 0.146 (0.00) 0.143 (0.00)
Self care worsening 0.026 (0.52) -0.000 (0.99) -0.007 (0.86) -0.002 (0.95)
Self care improvement 0.007 (0.86) 0.014 (0.71) 0.020 (0.60) 0.024 (0.54)
Usual activities worsening 0.043 (0.07) 0.059 (0.15) 0.056 (0.02) 0.054 (0.03)
Usual activities improvement 0.060 (0.04) 0.070 (0.15) 0.062 (0.03) 0.072 (0.01)
Pain/discomfort worsening -0.002 (0.92) -0.001 (0.98) -0.005 (0.84) 0.001 (0.98)
Pain/discomfort improvement -0.012 (0.72) -0.022 (0.50) -0.014 (0.67) -0.012 (0.72)
Anxiety/depression worsening -0.039 (0.08) -0.033 (0.12) -0.035 (0.010) -0.037 (0.08)
Anxiety/depression improvement -0.044 (0.12) -0.040 (0.15) -0.043 (0.12) -0.040 (0.15)
PATIENT AFTER-EFFECTS PRESENT
Behaviour 0.017 (0.37) 0.015 (0.38) 0.014 (0.43)
Learning disabilities -0.026 (0.21) -0.025 (0.23) -0.022 (0.31)
Scarring 0.015 (0.48) 0.009 (0.64) 0.010 (0.62)
Balance -0.080 (0.02) -0.081 (0.00) -0.086(0.00)
Speech/language 0.022 (0.42) 0.011 (0.67) 0.007 (0.80)
PATIENT HEALTHCARE (12 MONTHS)
GP 0.043 (0.02) 0.042 (0.03)
Outpatient -0.033 (0.10) -0.024 (0.23)
Inpatient 0.051 (0.10) 0.042 (0.18)
CARE-RELATED VARIABLES
Age (years) -0.001 (0.39)
Sex (male) -0.015 (0.57)
Biological relationship (Yes) 0.084 (0.03)
Co-resident (No) 0.032 (0.16)
Daily care (Yes) -0.005(0.83)
MODEL CHARACTERISTICS
Observations 206 206 206 206
F 2.64 2.63 2.71 2.42
R2 0.141 0.192 0.227 0.251
Adj R2 0.088 0.119 0.143 0.147
AIC -289 -291 -294 -291
https://doi.org/10.1371/journal.pone.0184886.t003
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patient’s mental health status or ability to self-care are more important predictors of carer out-
comes [57,64].
We developed an additional predictive model using variables related to the carer, alongside
patient variables, to assist in predicting ΔHC. The inclusion of care-related variables did
improve the explanatory power of the model and led to slightly better predictions within the
training sample. Clearly, accurate prediction of carer effects at an individual level requires
more than just information about the patient’s health state. However, importantly, the addi-
tional variables did not improve predictions in the testing sample. This finding highlights the
importance of using an external testing sample in predictive modelling. In the absence of an
external testing sample it would be tempting to conclude that the more complex predictive
models performed well, based on their greater explanatory power and predictive performance
in sample. We also explored whether the ΔHC for groups of carers could be predicted, as mean
changes in health status for groups of the population are the focus of economic evaluation.
This analysis suggested that predictive models may provide an indication of the magnitude of
ΔHC for groups of carers. Predictions are likely to be more favourable when examined at a
group level, because the various environmental influences on carers’ health will tend to cancel
out. Nevertheless the sub-group findings offer some encouragement for researchers who may
wish to generate predictions of mean health effects for carers at a group level in other settings.
The most likely reason for low predictive accuracy at the individual level lies in the nature
of the relationship between carer health status and patient health status. The findings in this
study are consistent with Wittenberg and Prosser’s (2013) assertion that patient illness has a
small detrimental impact on carer health that is highly context dependent. The limited ability
to predict ΔHC from patient variables is probably a sign that patient-related variables are one
of many factors likely to influence ΔHC. A carer’s health status for example is also likely to be
Table 4. Predictive accuracy of models of changes in carers’ health status.
Correlation between observed and predicted ΔHC (p value) Range of absolute errors MAE RMSE n
MODEL 1
Training sample 0.38 (0.00) 0.001 to 0.471 0.079 0.116 206
Testing sample 0.02 (0.78) 0.001 to 0.596 0.092 0.124 209
MODEL 2
Training sample 0.44 (0.00) 0.000 to 0.408 0.077 0.114 206
Testing sample 0.03 (0.64) 0.000 to 0.622 0.094 0.128 209
MODEL 3
Training sample 0.48 (0.00) 0.001 to 0.411 0.077 0.113 206
Testing sample 0.02 (0.81) 0.001 to 0.609 0.096 0.133 209
MODEL 4
Training sample 0.50 (0.00) 0.001 to 0.414 0.076 0.113 206
Testing sample 0.02 (0.75) 0.001 to 0.623 0.097 0.132 209
https://doi.org/10.1371/journal.pone.0184886.t004
Table 5. Observed and predicted meanΔHC in sub-groups of carer-patient dyads with full data (n = 415).
Observed ΔHC Predicted
ΔHC
One or more patient after-effect improved In sample (n = 42) -0.051 -0.040
Out of sample (n = 38) -0.021 -0.023
No change in any patient after-effects In sample (n = 106) -0.020 -0.022
Out of sample (n = 102) -0.008 -0.028
One or more patient after-effect worsened In sample (n = 38) -0.019 -0.022
Out of sample (n = 54) -0.035 -0.040
https://doi.org/10.1371/journal.pone.0184886.t005
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related to their own age and sex [36,65], their particular caring role, the amount of care pro-
vided [35,39], as well as various genetic and environmental factors [46], and even the country
they live in [66].
We did try to control for some of these additional variables and this did not improve our
ability to make out-of-sample predictions in the testing sample. This may be to be due to the
large number of predictor variables with relatively unstable relationships with ΔHC. This
means that coefficients that were optimised for use in the training sample may have been
poorly suited to the testing sample. Furthermore, the small sample size was likely to be an
issue. Splitting the dataset into training and testing samples halved the sample size and some of
the variables had a low proportion of observations in certain categories.
Despite the findings there are important lessons for future research and practice. First, it
seems very unlikely that a ‘one-size fits all’ model for predicting carer health status from
patient variables is possible. We found that the patient EQ-5D limitations that most impacted
on carers’ health status appeared to differ compared to what has been found in other studies
[57,64]. We also found that predictive performance of models in ostensibly similar samples
was very different. Second, it remains important to develop methods to better include carer
outcomes in economic evaluation. Our findings suggest that further research in this area
might be better focused on methods to collect data on carers’ outcomes, rather than to predict
those outcomes. This may require identifying the key contexts in which carer data ought to be
collected and developing methods for reaching carers and collecting a brief dataset that can
inform the subsequent economic evaluation. Developing better methods for estimating carer
and family effects has been highlighted as an important area of future research by the 2nd US
Panel on Cost-effectiveness [3].
In conclusion, predictive modelling of carer health status from patient data is attractive in
theory, but appears to be highly problematic in practice. Our findings show that–in the context
of long term afters of meningitis—predictive models can be estimated but performed poorly in
an external testing sample. These findings appear to be due to the highly-context dependent
relationship between carer and patient health status. These findings should not detract from
the pressing need to properly include carer outcomes in economic evaluation. In view of this,
efforts in research and practice efforts ought to focus on collecting carer data more routinely
to enable carer outcomes to be properly reflected in economic evaluation.
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